No abstract available
Publication types
-
Clinical Trial, Phase III
-
Letter
-
Comment
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Carcinoma, Non-Small-Cell Lung* / drug therapy
-
Carcinoma, Non-Small-Cell Lung* / pathology
-
Humans
-
Lung / pathology
-
Lung Neoplasms* / drug therapy
-
Lung Neoplasms* / pathology
Substances
-
Antibodies, Monoclonal, Humanized
-
cemiplimab
Associated data
-
ClinicalTrials.gov/NCT03409614